Find Academic Supervisors

Ryan M Hebert, MD, is an Assistant Professor of Neurosurgery at the Yale School of Medicine, affiliated with the Neurosurgery department. He specializes in neurovascular disorders, including open and endovascular treatments for intracranial aneurysms, arteriovenous malformations, carotid disease, and dural arteriovenous fistulas. He also focuses on interventions for ischemic and hemorrhagic strokes. His practice locations include Yale New Haven Hospital and Lawrence and Memorial Hospitals in Connecticut. Education & Training: Bachelor’s in Molecular, Cellular, and Developmental Biology from the University of Colorado – Boulder (Howard Hughes Undergraduate Research Grant recipient) MD from Yale School of Medicine (NIH-funded thesis on CCM3 in cerebral cavernous malformations) 7-year Neurosurgery Residency at Yale New Haven Hospital, including enfolded neuro-interventional training CAST-accredited fellowship in Endovascular Neurosurgery and Neurovascular Critical Care at Thomas Jefferson University Hospital (2016) Research Interests: Dr. Hebert’s work centers on emerging surgical and endovascular techniques for neurovascular disorders, risk stratification in carotid disease, vasospasm prediction/post-subarachnoid hemorrhage treatment, and outcomes of minimally invasive spine surgery. His studies often integrate clinical practice with translational research, emphasizing patient outcomes and procedural optimization. Key topics include flow diverters, cranial nerve palsies, hospital frailty risk scores, and immune mechanisms driving aneurysm rupture. Publications Trends: His recent articles emphasize clinical outcomes of endovascular procedures, stroke interventions, and immune mechanisms in aneurysm rupture. He frequently collaborates on meta-analyses and systematic reviews to evaluate treatment efficacy and complication rates, particularly involving cranial nerve recovery and thrombectomy volumes. Awards & Grants: He secured an NIH-funded thesis and a Howard Hughes Undergraduate research grant. No explicit scientific awards are listed, but his work has been recognized via peer-reviewed publications and contributions to clinical guidelines. Advising & Grants: While no students are listed, he collaborates with prominent researchers like Charles Matouk, Kevin Sheth, and Joseph Antonios on NIH-funded projects. His research addresses healthcare resource utilization and procedural volume impacts on mortality, indicating a focus on translational and clinical studies. Labs & Teams: Active in interdisciplinary teams at Yale School of Medicine, particularly in neurovascular critical care and endovascular surgery. Collaborates with the Stroke Center and Janeway Society for physician-scientist development.

• Neurovascular Surgery
• Cerebrovascular Disorders
• Stroke Intervention
• +3 more

Nida Latif is a Research Fellow in the Department of Internal Medicine at Yale School of Medicine. Her work focuses on understanding coronary microvascular dysfunction and ischemic heart disease in patients with nonobstructive coronary arteries, particularly in women. She is a key contributor to the DISCOVER INOCA multicenter registry, evaluating invasive coronary function testing protocols and diagnostic strategies. Her research integrates clinical, anatomical, and physiological data to improve diagnostic accuracy and patient outcomes. Key areas of investigation include coronary vasoreactivity testing, risk factor analysis in ischemic syndromes, and the impact of diabetes on angina pathophysiology. Latif's publications highlight advancements in coronary flow reserve measurement, comparison of diagnostic modalities (e.g., PET vs thermodilution), and the clinical utility of vessel-specific analysis. Her work emphasizes translational outcomes, bridging basic science insights with clinical practice improvements. While no specific awards are listed, her contributions to high-impact clinical registries and peer-reviewed publications reflect her active role in advancing cardiovascular medicine.

• Cardiovascular Disease
• Coronary Microvascular Dysfunction
• Invasive Coronary Function Testing
• +3 more

Dr. Nivee Pradip Amin serves as Clinical Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at NewYork-Presbyterian Hospital, holding leadership roles as Associate Director for Consultative Cardiology and Director of the Women's Heart Program & Preventive Cardiology. Her clinical expertise spans general cardiology, preventive cardiology, and echocardiography with focus on high-risk cardiovascular prevention. Her educational credentials include: B.A., B.S. in International Studies and Business from University of Pennsylvania (2002) M.D. from Johns Hopkins University School of Medicine (2007) M.H.S. in Clinical Investigation from Johns Hopkins Bloomberg School of Public Health (2013) Research centers on sex-based disparities in cardiovascular outcomes, women's heart health across the lifespan, and preventive strategies for coronary/valvular disease. She investigates intersections between cardiology and obstetrics/oncology, emphasizing personalized risk assessment and early intervention to improve quality of life. Analysis of her publications reveals consistent focus on women's cardiovascular biomarkers (e.g., breast arterial calcium), obstetric complications as long-term risk factors, and disparities in revascularization outcomes. Her work leverages large-scale database analysis to address gaps in preventive care for high-risk populations including cancer patients and those with cirrhosis. Dr. Amin maintains active board certifications in Internal Medicine, Cardiovascular Diseases, Nuclear Cardiology, and Echocardiography through the American Board of Internal Medicine, and holds professional memberships in the American College of Cardiology, American Society for Preventive Cardiology, and American Heart Association. She provides inpatient consultative care on cardiac telemetry units while leading the Women's Heart Program, which integrates preventive cardiology services with gender-specific treatment protocols. Fluent in Spanish, she emphasizes culturally competent care tailored to individual patient needs across diverse populations.

• Cardiovascular Disease
• Women's Cardiovascular Health
• Preventive Cardiology
• +3 more

Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.

• Cardiac Surgery
• Heart Valve Disease
• Transcatheter Valve Interventions
• +7 more

Dr. Michael S. Conte is Professor of Surgery at the University of California, San Francisco (UCSF) School of Medicine, where he serves as Co-director of the UCSF Heart & Vascular Center and Chief of the Division of Vascular & Endovascular Surgery. Specializing in vascular surgery, Dr. Conte focuses on diseases of the aorta, aneurysms, carotid artery disease, peripheral artery disease (PAD), and diabetic vascular disease, performing complex revascularization procedures to preserve limb function and prevent amputations. Dr. Conte received his medical degree from Albert Einstein College of Medicine in 1986, completed surgical residency at Weill Cornell Medicine, and vascular surgery training at Brigham and Women's Hospital and Harvard Medical School. His clinical and research work has significantly advanced the field of vascular surgery, particularly in chronic limb-threatening ischemia (CLTI) management. Dr. Conte's research interests center on vascular interventions, limb preservation strategies, diabetic foot complications, and vascular disease outcomes. He led the largest multicenter clinical trial of leg bypass surgery for severe PAD and has been instrumental in the BEST-CLI trial comparing surgical versus endovascular approaches for CLTI. His work investigates mechanisms of vascular injury response, angioplasty and bypass failure, and methods to identify patients at risk for poor outcomes. Analysis of Dr. Conte's recent publications (2023-2025) reveals a strong emphasis on CLTI management, diabetic foot care, health disparities in vascular treatment, and quality improvement in vascular surgery. His research spans clinical trials, systematic reviews, guideline development, and health services research, demonstrating consistent contributions to evidence-based vascular care. American Heart Association 2019 Peripheral Vascular Disease Distinguished Achievement Award San Francisco Magazine 2016 Bay Area Top Doctors Best Doctors, Inc. 2015 Best Doctors in America New York Weill Cornell Medical Center Alumni Council 2006 Distinguished Achievement Award NHLBI/Lifeline 1999 Mentored Clinical Scientist Development Award Dr. Conte has secured significant NIH funding for research on diabetic foot care and vascular interventions, serving as Principal Investigator on multiple grants including the UCSF Diabetic Foot Clinical Research Unit (NIH U01DK119100) and research on specialized lipid mediators in vascular injury (NIH R01HL119508). He has established multidisciplinary 'toe and flow' programs at UCSF focused on limb preservation for patients with diabetic foot complications. As an active member of the Society for Vascular Surgery and Society of University Surgeons, Dr. Conte serves on editorial boards for leading vascular journals and has contributed to clinical practice guidelines. His clinical practice emphasizes complex revascularization procedures, and he is board certified in Vascular Surgery by the American Board of Surgery.

• Vascular Surgery
• Peripheral Artery Disease
• Aortic Disease
• +7 more

Prof. Dr. med. Zsolt Kulcsár is Director of the Department of Neuroradiology at the University Hospital Zurich (USZ) and a board member of the Clinical Neurocenter. He is an internationally recognized interventional neuroradiologist with expertise in the diagnosis and endovascular treatment of complex neurovascular diseases—including cerebral arteriovenous malformations, dural arteriovenous fistulas, aneurysms, and acute stroke—as well as pediatric cerebrovascular malformations and pulse-synchronous tinnitus. Education & Academic Qualifications 2006 – Specialist in Radiology, Semmelweis University, Budapest 2008 – Specialist in Neuroradiology, Semmelweis University, Budapest 2012 – Dr. phil. (PhD) in Clinical Neuroscience, Semmelweis University, summa cum laude 2013 – Habilitation & Venia Legendi in Diagnostic Radiology, University of Essen-Duisburg, Germany 2015 – Re-certification (Umhabilitation), Faculty of Medicine, University of Geneva 2016 – Promotion to Professor Assistant , University of Geneva Research Focus Prof. Kulcsár’s research concentrates on three pillars: (1) aneurysm biology and hemodynamics , exploring how wall shear stress and flow patterns influence aneurysm evolution; (2) novel neuroendovascular techniques and materials , including intra-saccular biological fillers and liquid embolics for vascular malformations; and (3) revascularization strategies in acute ischemic stroke . Pre-clinical studies are conducted in collaboration with the Musculoskeletal Research Unit (MSRU) of the Vetsuisse Faculty, while multicentre clinical trials validate new devices and treatment paradigms. Professional Service & Leadership President, European Society of Minimally Invasive Neurological Therapy (ESMINT) 2022-2024 Secretary-General, ESMINT 2020-2022 Treasurer, ESMINT 2018-2020 Chair, ESMINT Industrial Liaison Committee 2014-2018 Member, Executive Committee, ESMINT 2012-2018 Medical Director, ESMINT Portal 2012-2017 Board member, Swiss Society of Neuroradiology (SGNR) since 2022 Editorial roles: Associate Editor Journal of Neuroradiology ; Editorial Committees Clinical Neurosciences and Neuroradiology Laboratory & Collaborative Networks Prof. Kulcsár leads an integrated clinical-experimental program that bridges the USZ Department of Neuroradiology with the MSRU pre-clinical imaging platform and multiple industry partners. The team develops next-generation endovascular devices and biologically active embolic materials, translating findings from bench-top flow models to first-in-human trials.

• Neurovascular diseases
• Cerebral aneurysms and vascular malformations
• Neuroendovascular interventions
• +2 more

Associate Professor Abdul Ihdayhid is a Research Leader in Cardiovascular Biology at the Curtin Medical School , Curtin University, within the Faculty of Health Sciences. His work focuses on advanced cardiac imaging techniques, particularly coronary CT angiography, fractional flow reserve modeling, and AI integration in cardiovascular diagnostics. Key Research Areas: Cardiovascular imaging, artificial intelligence applications, aortic stenosis interventions, and ethical implications of AI in medicine. Recent Publications: Analysis of high-risk coronary plaque, telehealth adaptations during pandemics, and AI-driven CAC scoring innovations. Collaborations: Extensive partnerships with institutions across Australia and New Zealand on multicenter studies like the Australian-New Zealand SCAD cohort. His 2024-2025 work emphasizes machine learning for plaque quantification and ethical frameworks in AI implementation. Email: Abdul.Ihdayhid@curtin.edu.au

• Cardiovascular Medicine
• Cardiac Imaging
• Artificial Intelligence in Cardiology
• +3 more

Adam de Havenon, MD, MSCI is an Associate Professor of Neurology at Yale School of Medicine specializing in vascular neurology. He leads the de Havenon Lab which focuses on reducing stroke risk, preventing recurrent strokes, and improving post-stroke recovery outcomes. His clinical practice includes evaluating and treating acute strokes in hospital and emergency settings, as well as providing outpatient stroke consultations. Dr. de Havenon earned his BA in American Studies from Yale University in 2001, followed by his MD from Brown Medical School in 2009. He completed neurology residency at the University of Utah in 2013 and a vascular neurology fellowship at University of Washington in 2014. In 2021, he completed a Masters of Science in Clinical Investigation degree. After serving as faculty at the University of Utah from 2014-2021, he returned to Yale in late 2021. His research spans intracranial atherosclerosis, blood pressure variability, vascular cognitive impairment, white matter hyperintensity, and advanced neuroimaging techniques. Dr. de Havenon has published over 150 peer-reviewed articles and his work focuses on bridging basic science of stroke research with human implementation. His publications from 2024-2025 demonstrate strong emphasis on stroke risk prediction, vascular risk factor management, neuroimaging techniques, and health disparities in stroke outcomes. Dr. de Havenon has secured competitive grant funding including K23, R01, and UG3/UH3 awards from NIH/NINDS. He serves as principal investigator for the BP-VISO study and StrokeNet study CAPTIVA-MRI. His mentees have received prestigious awards including NIH NRS training grants and American Academy of Neurology Medical Student Research Scholarships. He established the de Havenon Lab first at his prior institution and then at Yale in 2022, where it continues to expand its footprint in cerebrovascular research and training the next generation of researchers. The lab's mission is to advance research that benefits stroke patients while addressing gaps and disparities in stroke prevention and care.

• Stroke
• Vascular Neurology
• Intracranial Atherosclerosis
• +5 more

Mirza Umair Khalid, M.D., is an Assistant Professor in the Department of Medicine-Cardiology at Baylor College of Medicine and Director of the Cardiac Care Unit at the Michael E. DeBakey VA Medical Center in Houston. He holds dual roles as Associate Program Director (Academics) for the Cardiology Fellowship Program and Clinical Educator. His academic portfolio includes over 70 peer-reviewed publications and active leadership in national committees like the American College of Cardiology's PINNACLE R&P Committee. Dr. Khalid completed his MBBS at Aga Khan Medical School (2009), followed by Internal Medicine residency and Cardiology fellowship at Baylor College of Medicine (2013–2018). Research focuses on intracoronary imaging, structural echocardiography, and complex coronary interventions. He leads quality improvement initiatives in the VA CCU and oversees BCM Cardiology Fellowship’s academic training, including lecture series, board review, and M&M conferences. Awards include the BCM Early Career Award (2021) and recognition as Best Teaching Faculty (2020). Professional memberships span the American College of Cardiology, American Heart Association, and National Cardiovascular Data Registry (NCDR) committees. His clinical expertise spans six certifications, including Interventional Cardiology, Echocardiography, and Cardiac CT.

• Intracoronary Imaging
• 3D and Structural Echocardiography
• Invasive Cardiac Hemodynamics
• +3 more

Dr. Tze-Woei Tan is a Clinical Associate Professor in the Department of Surgery at the Keck School of Medicine, University of Southern California, where he directs the Limb Salvage Research Program. He holds an MD from the University of Melbourne, completed residency at Brown University, vascular surgery fellowship at Boston University, and an MPH from the University of Arizona. His NIH-supported research focuses on reducing amputations in peripheral artery disease and diabetes through innovative interventions. Research explores health disparities, minimally invasive surgical techniques, and diabetic vascular complications. Recent work investigates telemedicine applications in acute care, frailty assessment in surgical outcomes, and racial disparities in amputation recovery. Articles consistently address integrated care models for complex vascular conditions and diabetic foot ulcer prevention. Honors include the Roger E. Pecoraro Award from the American Diabetes Association (2023) and the Keck Faculty Teaching Award (2024). Leads NIH-funded projects on limb preservation and mentors trainees in clinical research methodologies. Directs the Limb Salvage Research Lab, collaborating with podiatry, endocrinology, and health policy experts to develop multidisciplinary care pathways for high-risk populations.

• Vascular Surgery
• Peripheral Artery Disease
• Diabetes
• +4 more

Alessandro Castiglioni is an Associate Professor of Cardiac Surgery at Vita-Salute San Raffaele University and Head of the Cardiac Surgery Unit at IRCCS San Raffaele Hospital. He specializes in structural heart disease surgery, particularly mitral valve repair and transcatheter aortic valve interventions (TAVI). His roles include leadership in the Aortic Team Project and TAVI Project, and he serves as Secretary and Associate Professor in the University's Cardiac Surgery School of Specialization. Affiliations: IRCCS San Raffaele Hospital (Cardiac Surgery Unit Head), Humanitas Mater Domini (Consultant Cardiac Surgeon), and Guido Salvinii Public Hospital (Consultant). Education: MD from University of Milan (1993), Specializations in Thoracic Surgery (1998) and Cardiac Surgery (2007), National Scientific Qualification as Associate Professor (2017). Research focuses on valve disease management, surgical innovation (e.g., ReverseTWO cardioplegia system), and multidisciplinary aortic aneurysm care. He actively reviews for the European Journal of Cardiothoracic Surgery and participates in major professional associations. Teaching includes courses on hybrid myocardial revascularization, cardiac surgery in elderly patients, and ischemic cardiopathy techniques at Vita-Salute San Raffaele University.

• Cardiac Surgery
• Heart Valve Surgery
• Structural Heart Disease
• +6 more

Dr. Albert J. Sinusas is a Professor of Medicine (Cardiology) , Radiology & Biomedical Imaging , and Biomedical Engineering at Yale University . He serves as Director of the Yale Translational Research Imaging Center (Y-TRIC) and Advanced Cardiovascular Imaging at Yale New Haven Hospital. Education: BS from Rensselaer Polytechnic Institute (1979), MD from University of Vermont (1983), Internal Medicine training at University of Oklahoma (1986), Cardiology/Nuclear Cardiology at University of Virginia (1989) Dr. Sinusas specializes in non-invasive cardiovascular imaging with expertise in PET/CT, SPECT/CT, echocardiography, and MR imaging . His research focuses on molecular imaging of myocardial injury , angiogenesis , post-infarction remodeling , and deep learning applications in cardiac diagnostics. He has pioneered multimodality imaging approaches for cardiovascular pathophysiology assessment. Recent publications highlight his work in AI-driven cardiac imaging , novel PET tracers , and medical robotics . His team's 15 most recent articles (2024-2025) span topics from ARDS diagnostics to cardiovascular risk stratification using CT and PET technologies. Scientific Awards: SNMMI Hermann Blumgart Award (2008) Best Doctor in America (2001-2002, 2005-2015) M.A. Privatim from Yale (2006) Robert Wilkinson Lectureship (2014) Interurban Clinical Club membership (2017) As Principal Investigator on multiple NIH grants, Dr. Sinusas directs the NHLBI-funded T32 training program in multimodality cardiovascular imaging. His lab (Y-TRIC) houses state-of-the-art imaging resources including hybrid SPECT/CT , microCT , and 3D ultrasound systems for translational research from animal models to clinical applications.

• Cardiovascular Imaging
• Translational Research
• Molecular Imaging
• +9 more

Alejandro R. Chade, MD, is a Professor of Medical Pharmacology and Physiology at the University of Missouri School of Medicine and a NextGen Precision Health Investigator. His research focuses on cardiovascular and renal physiologic imaging, microcirculatory function, and mechanisms of renal and cardiac disease. Dr. Chade’s laboratory develops translational swine models of chronic kidney disease (CKD) and hypertension, leveraging advanced imaging techniques such as multi-detector CT and echocardiography to study renal and cardiac function. His work also explores novel therapeutic strategies targeting the renal and cardiac microcirculation to mitigate inflammation and improve organ function. Education: MD from Universidad Nacional de Cuyo (1996), Cardiology Residency and Fellowship at Hospital Lagomaggiore (2001), and postdoctoral training at the Mayo Clinic (2005). He has held roles at the University of Mississippi Medical Center before joining the University of Missouri. Research Interests include mechanisms linking CKD to cardiovascular disease, imaging-based diagnostics, and drug delivery systems for targeted therapies. His lab investigates macrophage polarization, NF-kB signaling pathways, and the role of mitochondrial DNA in renal injury. Key Awards: American Heart Association Established Investigator Award, Mid-Career Award, and numerous travel and recognition awards for hypertension and renal research. Publications focus on swine models, renal-cardiac crosstalk, and VEGF-based therapies, with high-impact contributions to American Journal of Physiology and Hypertension . Labs/Teams: Leads the NextGen Precision Health Initiative, collaborating on translational research to bridge basic science and clinical applications.

• Cardiovascular Physiology
• Renal Disease Mechanisms
• Microcirculatory Function
• +3 more

Dr. Keith Oldroyd is an Honorary Professor at the University of Glasgow's School of Cardiovascular & Metabolic Health. His research focuses on coronary physiology, myocardial infarction, and interventional cardiology, with a particular emphasis on fractional flow reserve (FFR) and coronary microvascular dysfunction. He leads major clinical trials such as CorMicA and FAMOUS-NSTEMI, assessing diagnostic and therapeutic strategies in coronary artery disease. Key contributions include advancing understanding of coronary microvascular dysfunction, optimizing PCI outcomes, and evaluating the clinical impact of influenza vaccination post-MI. Collaborations with institutions globally highlight interdisciplinary work in drug-eluting stents, biomaterials, and cardiovascular imaging. Over 150 peer-reviewed publications (2001–2024) Principal Investigator for CorMicA trial Leadership in Glasgow PRAMI and EVOLVE 48 studies Labs/Teams: Active in translational cardiology research at the Golden Jubilee National Hospital and University of Glasgow's cardiovascular imaging and intervention teams.

• Cardiovascular Medicine
• Coronary Artery Disease
• Fractional Flow Reserve
• +6 more

Andrew DeWan is an Associate Professor of Epidemiology (Chronic Diseases) at the Yale School of Public Health, serving as Co-Director of the Yale Center for Perinatal, Pediatric and Environmental Epidemiology and Director of Graduate Studies. He holds a PhD in Statistical Genetics (Rockefeller University), an MPH in Epidemiology (University of Minnesota), and a BS in Biology (Brandeis University). His research focuses on genetic epidemiology, particularly identifying genetic susceptibility variants for complex traits like asthma, obesity, leukemia, preeclampsia, and bacterial infections. He employs strategies to reduce phenotypic heterogeneity, such as ancestry-based stratification and genetic interaction analysis. His work includes large-scale GWAS and exome sequencing studies, with a focus on pleiotropy and rare variant mapping. Research Highlights Identified genetic variants linked to age-related macular degeneration, asthma, and leukemia. Developed methods for analyzing gene-gene interactions and pleiotropy in complex traits. Principal Investigator of multiple NIH grants, including three R01 awards. Teaches courses like Genetic Concepts in Public Health and collaborates internationally on genetic epidemiology projects. His research emphasizes leveraging genomic data to improve understanding of disease mechanisms, with applications in personalized medicine and public health. He has published extensively in top journals and serves on committees such as the American Society of Human Genetics Program Committee.

• Genetic Epidemiology
• Complex Traits
• Asthma
• +8 more